This inventor holds 1 USPTO granted patent. Top assignee: Taipei Medical University. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Jan-Show Chu: Innovator in Breast Cancer Research
Introduction
Jan-Show Chu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, particularly in the area of breast cancer treatment. His innovative work focuses on the development of small interfering RNAs (siRNAs) that target specific receptors associated with tumorigenesis.
Latest Patents
Jan-Show Chu holds a patent for "Small interfering RNAs and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer." This invention identifies the overexpression and activation of the α9-nAChR receptor as a key factor in breast cancer tumorigenesis. By creating a series of siRNAs, he aims to inhibit the expression of α9-nAChR, thereby providing a method to prevent, inhibit, or treat the malignant progression of breast cancer induced by nicotine-derived compounds.
Career Highlights
Jan-Show Chu is affiliated with Taipei Medical University, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential impact on breast cancer therapies, making him a notable figure in the medical research community.
Collaborations
He collaborates with esteemed colleagues such as Chia-Hwa Lee and Ching-Shui Huang, contributing to a dynamic research environment focused on advancing cancer treatment methodologies.
Conclusion
Jan-Show Chu's innovative approach to breast cancer treatment through the development of siRNAs highlights his commitment to improving patient outcomes. His work represents a significant advancement in the fight against cancer, showcasing the importance of research and innovation in medical science.